{"log_id": 8638743946430724354, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 1.1e-05, "average": 0.99833, "min": 0.982186}, "location": {"width": 775, "top": 218, "height": 37, "left": 210}, "words": "很可能是达托霉素的肾清除率间存在差异。肥胖患者使用本品时无需调整剂量"}, {"probability": {"variance": 0, "average": 0.999408, "min": 0.999033}, "location": {"width": 92, "top": 272, "height": 26, "left": 259}, "words": "儿童用药"}, {"probability": {"variance": 0.008936, "average": 0.975323, "min": 0.510278}, "location": {"width": 535, "top": 310, "height": 35, "left": 256}, "words": "在儿童人群中(《18岁)尚未建立达托霉素的药代动力学"}, {"probability": {"variance": 0.026146, "average": 0.941756, "min": 0.484437}, "location": {"width": 200, "top": 357, "height": 29, "left": 255}, "words": "药物-药物相互作用"}, {"probability": {"variance": 0, "average": 0.999603, "min": 0.999285}, "location": {"width": 94, "top": 406, "height": 26, "left": 256}, "words": "体外研究"}, {"probability": {"variance": 6e-06, "average": 0.998045, "min": 0.988357}, "location": {"width": 744, "top": 444, "height": 35, "left": 255}, "words": "对人肝细胞的体外研究表明,达托霉素并不抑制或降低以下人细胞色素P450"}, {"probability": {"variance": 0.006843, "average": 0.974337, "min": 0.561697}, "location": {"width": 789, "top": 490, "height": 31, "left": 209}, "words": "同工型的活性:1A2、2A6、2C9、2C19、206、2E1和3A4,而且达托霉素不"}, {"probability": {"variance": 1.5e-05, "average": 0.997135, "min": 0.988828}, "location": {"width": 453, "top": 536, "height": 30, "left": 212}, "words": "太可能抑制或诱导由P450系统进行的药物代谢"}, {"probability": {"variance": 0.043188, "average": 0.851198, "min": 0.557306}, "location": {"width": 74, "top": 582, "height": 27, "left": 255}, "words": "氨曲南"}, {"probability": {"variance": 1e-05, "average": 0.998025, "min": 0.987304}, "location": {"width": 743, "top": 622, "height": 29, "left": 258}, "words": "在1项研究中,15名健康成人受试者接受单次静脉给予本品6mg/kg和静脉"}, {"probability": {"variance": 0.000994, "average": 0.990481, "min": 0.812704}, "location": {"width": 790, "top": 666, "height": 30, "left": 211}, "words": "给予本品6mg/kg与静脉给予氨曲南1g两药联合使用。结果表明,氨曲南没有引"}, {"probability": {"variance": 0.000891, "average": 0.982774, "min": 0.886985}, "location": {"width": 337, "top": 713, "height": 29, "left": 210}, "words": "起达托霉素C和AUC的明显改变"}, {"probability": {"variance": 0, "average": 0.999809, "min": 0.999427}, "location": {"width": 94, "top": 760, "height": 27, "left": 257}, "words": "妥布霉素"}, {"probability": {"variance": 1.4e-05, "average": 0.997862, "min": 0.982509}, "location": {"width": 745, "top": 801, "height": 29, "left": 258}, "words": "在一项研究中,6名健康成人男性接受单次静脉给予2mg/kg本品、单次静脉"}, {"probability": {"variance": 0.000345, "average": 0.993514, "min": 0.892228}, "location": {"width": 793, "top": 842, "height": 38, "left": 209}, "words": "给予1mg/kg妥布霉素以及两药联合使用。结果表明,当与妥布霉素联用时,达托"}, {"probability": {"variance": 0.02295, "average": 0.935555, "min": 0.369095}, "location": {"width": 790, "top": 889, "height": 30, "left": 211}, "words": "霉素的平均Cm和AUC分别增加12.7%和8.7%;妥布霉素的平均Cx和AU在联用"}, {"probability": {"variance": 0.000289, "average": 0.995265, "min": 0.891559}, "location": {"width": 791, "top": 932, "height": 34, "left": 211}, "words": "时分别降低10.7%和6.6%。这些差异无统计学意义。在本品的临床剂量下,达托"}, {"probability": {"variance": 6e-06, "average": 0.998182, "min": 0.991058}, "location": {"width": 390, "top": 981, "height": 29, "left": 211}, "words": "霉素和妥布霉素间的相互作用尚不清楚"}, {"probability": {"variance": 0.050089, "average": 0.863866, "min": 0.476407}, "location": {"width": 150, "top": 974, "height": 60, "left": 940}, "words": "金园信海"}, {"probability": {"variance": 0, "average": 0.999135, "min": 0.998721}, "location": {"width": 70, "top": 1028, "height": 28, "left": 260}, "words": "华法林"}, {"probability": {"variance": 4.5e-05, "average": 0.995697, "min": 0.968061}, "location": {"width": 745, "top": 1066, "height": 35, "left": 260}, "words": "在16名健康受试者中,静脉给予本品(6mg/kgq24h)5天后单次经口给予华"}, {"probability": {"variance": 0.006451, "average": 0.981259, "min": 0.506289}, "location": {"width": 792, "top": 1110, "height": 35, "left": 213}, "words": "法林(25mg)。结果发现,该伴随用药对两药的药代动力学均无明显影响号并且未"}, {"probability": {"variance": 0.002481, "average": 0.982598, "min": 0.786536}, "location": {"width": 367, "top": 1158, "height": 30, "left": 214}, "words": "引起INR的明显改变(国际标准化比值"}, {"probability": {"variance": 0.001859, "average": 0.97402, "min": 0.899375}, "location": {"width": 94, "top": 1205, "height": 28, "left": 260}, "words": "辛伐他汀"}, {"probability": {"variance": 0.00112, "average": 0.989289, "min": 0.811799}, "location": {"width": 748, "top": 1244, "height": 35, "left": 258}, "words": "对每日使用稳定剂量40mg辛伐他汀的20名健康受试者,连续14天静脉给予本"}, {"probability": {"variance": 0.001203, "average": 0.990332, "min": 0.778524}, "location": {"width": 793, "top": 1289, "height": 36, "left": 214}, "words": "品4mg/kgq24h(N=10),对辛伐他汀血浆谷浓度没有影响;与每日使用一次安"}, {"probability": {"variance": 3.9e-05, "average": 0.996483, "min": 0.974788}, "location": {"width": 794, "top": 1334, "height": 35, "left": 213}, "words": "慰剂的受试者相比(N=10),并未见更高的包括骨骼疾病的不良事件发生率(见注"}, {"probability": {"variance": 4.6e-05, "average": 0.996726, "min": 0.97599}, "location": {"width": 241, "top": 1383, "height": 28, "left": 214}, "words": "意事项和药物相互作用)"}, {"probability": {"variance": 1e-06, "average": 0.998935, "min": 0.997906}, "location": {"width": 72, "top": 1430, "height": 26, "left": 261}, "words": "丙磺舒"}, {"probability": {"variance": 0.000499, "average": 0.99282, "min": 0.867696}, "location": {"width": 745, "top": 1476, "height": 34, "left": 262}, "words": "同时给予丙磺舒(每日4次共500mg)和静脉给予本品4mg/kg时,未引起达"}, {"probability": {"variance": 0.060205, "average": 0.880363, "min": 0.217135}, "location": {"width": 311, "top": 1525, "height": 30, "left": 214}, "words": "托霉素 Cmr Ek AUCO的明显改变"}], "language": 3}